Showing results (211-220 of 425) with videos related to

Sort By:
Pageof 43
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excisionMin Yi, Funda Meric-Bernstam, Henry M Kuerer, et al.
Cancer|October 20, 2011
Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancerYun Wu, Elizabeth A Mittendorf, Canan Kelten, et al.
American Journal of Surgery|January 22, 2008
Melanoma adrenal metastasis: natural history and surgical managementElizabeth A Mittendorf, Sherry J Lim, Chris W Schacherer, et al.
Annals of Surgical Oncology|May 21, 2014
Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?Elizabeth A Mittendorf, Abigail S Caudle, Wei Yang, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 1, 2024
Concordance of PD-L1 Expression in Metastatic Triple-negative Breast Cancer Between the 22C3 and E1L3N Antibodies Using Combined Positive ScoringTimothy K Erick, Susan C Lester, Ana C Garrido-Castro, et al.
Annals of Surgery|September 5, 2009
Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patientsKelly K Hunt, Min Yi, Elizabeth A Mittendorf, et al.
Annals of Surgical Oncology|May 27, 2014
Predicting the extent of nodal disease in early-stage breast cancerAbigail S Caudle, Henry M Kuerer, Huong T Le-Petross, et al.
Breast Cancer Research and Treatment|August 4, 2025
Assessing racial disparities in disease outcomes of patients with high-risk, triple-negative breast cancer and residual disease after neoadjuvant therapy: a post-hoc analysis of the ECOG-ACRIN 1131 clinical trialKate Lloyd, Lisa A Newman, Charity Glass, et al.
NPJ Breast Cancer|July 3, 2025
Dynamic single-cell systemic immune responses in immunotherapy-treated early-stage HR+ breast cancer patientsXiaopeng Sun, Margaret L Axelrod, Adrienne G Waks, et al.
Annals of Surgical Oncology|August 21, 2013
Clinical course of breast cancer patients with isolated sternal and full-thickness chest wall recurrences treated with and without radical surgeryMichelle C Shen, Nader N Massarweh, Sara A Lari, et al.
Pageof 43